Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2012

View Archived Issues

Danish company divulges novel CaS receptor agonists

Novel urate-lowering compound shows potential as a treatment for gout

Merck Serono patents new GM-CSF-directed immunotherapies

Results from several dapagliflozin trials disclosed

Famitinib metabolism investigated in clinical and in vitro studies

Novel oncolytic targets p53/Mdm2 interaction

Novel S1P1 receptor modulators reported by Allergan

Symbicort Turbuhaler obtains additional approval in Japan

Spanish group presents novel immunomodulators

Almirall develops new Janus kinase inhibitors

Stemergie Biotechnology discovers novel agents for cancer

Alexza provides update on Adasuve submissions

Ongoing meeting features presentations on PTHrP analogue for postmenopausal osteoporosis

Two phase III Flutiform trials meet primary endpoint

Repligen receives complete response letter for RG-1068 NDA

New agents for RSV infection disclosed by Biota Scientific Management

European CHMP adopts opinion on teduglutide

Genkyotex reports phase Ia data on GKT-137831

Novel prostanoid DP2 receptor antagonists designed in Spain

Astex kicks off phase II expansion segment of SGI-110 trial

Cellceutix clear to launch clinical development of anticancer drug

Theratechnologies gives update on tesamorelin regulatory progress

EMA committee issues opinion on taliglucerase alfa

Emend approved for additional indication in Japan

EMA committee recommends approval of intravenous cephalosporin antibiotic

Astellas Pharma set to launch Kiklin capsules in Japan

EMA committee issues opinion on Seebri Breezhaler

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...